BALYASNY ASSET MANAGEMENT L.P. - 10X GENOMICS INC ownership

10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 250 filers reported holding 10X GENOMICS INC in Q2 2022. The put-call ratio across all filers is 0.59 and the average weighting 1.0%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of 10X GENOMICS INC
ValueSharesWeighting
Q1 2023$41,388,425
+2934.3%
741,861
+2360.9%
0.10%
+2500.0%
Q2 2022$1,364,000
-61.8%
30,146
+52.6%
0.00%
-77.8%
Q1 2021$3,575,000
-57.3%
19,751
-66.6%
0.02%
-60.9%
Q4 2020$8,363,000
+629.1%
59,063
+359.7%
0.05%
+360.0%
Q2 2020$1,147,00012,8480.01%
Other shareholders
10X GENOMICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 1,358,528$49,504,760100.00%
Meritech Capital Associates V L.L.C. 1,061,682$38,687,6929.44%
Decheng Capital Management III (Cayman), LLC 359,554$13,102,1484.90%
Sands Capital Ventures, LLC 481,770$17,5564.81%
Whitford Management LLC 58,310$2,124,8032.88%
FINANCIAL CONSULATE, INC 156,457$5,701,2931.99%
SRS Investment Management, LLC 3,005,427$109,517,7601.98%
BRANDYWINE MANAGERS, LLC 11,208$408,4201.43%
ARK Investment Management 4,316,567$157,295,7011.36%
Nikko Asset Management Americas, Inc. 2,177,988$79,365,8831.14%
View complete list of 10X GENOMICS INC shareholders